KPSGILL Intelligence
Medicine and the institutions that shape it.
Explored by a physician. Grounded in evidence.
Type a question in ordinary words. Answers are grounded in retrieved KPSGILL pages and identified sources; questions the library cannot support are declined rather than answered from model memory. No advice is given, and no personal health information is accepted.
616 current articles: 482 policy analyses, 128 patient guides, 3 standing trackers and 3 cross-cutting essays, plus 15 superseded records kept at their original addresses. Ask in your own words.
This week’s records, read at the bodies that issued them. Each carries its instrument, its state and its source — a proposal is not law, an agenda is not a decision, and a closed comment period is not a final rule. Updated 18 August 2026.
A discussion paper issued asks how generative-AI devices should be assessed for risk, evaluated before market and monitored after it — including a premarket model built on competency assessment. It is not a rule and not guidance: FDA states it proposes no policy. Feedback to docket FDA-2026-N-7874 closes 19 October.
Discussion paper · FDA Center for Devices and Radiological Health
The comment period on the proposed rule for the Medicare Drug Price Negotiation Program and the Part D benefit closed . Two state axes move separately: the window is closed and the rule is still a proposal. Nothing became final on that date.
Proposed rule · Centers for Medicare & Medicaid Services
Licensing Panels A and B sit 19 August; the quarterly Board meeting runs 20 and 21 August. Materials are published and the meeting is upcoming — two separate states, neither of them a decision. Records are created for actions the Board actually takes, not for items merely listed.
Bagley-Keene agenda · Medical Board of California
From 21 August 2026 a refill is blocked where the member has not used enough of the previous fill of the same medication. It reaches the pharmacy counter directly, and the override path matters more than the threshold.
Benefit policy change · DHCS — Medi-Cal Rx
OIG reviewed sessions billed to Medicare between 1 October 2023 and 30 September 2024. Of a 100-session sample, 72 did not comply with Medicare requirements. An audit finding is not a fraud finding and not a rule change.
Audit report · HHS Office of Inspector General
A consultation running 13 August to 2 October 2026 on expanding what the TGA may lawfully release about medical devices under section 61 of the Therapeutic Goods Act 1989. A consultation is not a decision.
Consultation · Therapeutic Goods Administration
On 6 August 2026 the FDA granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), an HSV-1 oncolytic viral therapy, with nivolumab, for anti-PD-1 refractory disease. Accelerated approval rests on a surrogate endpoint and carries a confirmatory-trial obligation.
Marketing authorisation · Food and Drug Administration
Every page names its reviewing physician and its review date. Where claim-level authority has been mapped, the evidence can be inspected directly, down to the instrument each proposition rests on. Nothing is deleted. A page that fails an audit is rewritten from primary sources, or merged into the canonical page and kept at its own address as a superseded record with its original text retained. Editorial standards & ledger
Kanwar Partap Singh Gill, MD
Family Medicine Physician · Fresno, California
The physician
AboutProfessional ProfileCredentialsWho is KPS Gill, MD?Approach to CareAreas of CareCurrent Practice